Global patent index - EP 0973521 A1

EP 0973521 A1 2000-01-26 - CYCLOPENTYLXANTHINE DERIVATIVES FOR USE IN THE TREATMENT OF CYSTIC FIBROSIS

Title (en)

CYCLOPENTYLXANTHINE DERIVATIVES FOR USE IN THE TREATMENT OF CYSTIC FIBROSIS

Title (de)

CYCLOPENTYLXANTHINEDERIVATE FÜR DIE VERWENDUNG IN DIE BEHANDLUNG VON ZYSTISCHER FIBROSE

Title (fr)

UTILISATION DE DERIVES DE LA CYCLOPENTYLXANTHINE DANS LE TRAITEMENT DE LA MUCOVISCIDOSE

Publication

EP 0973521 A1 (EN)

Application

EP 97911336 A

Priority

  • GB 9703036 W
  • GB 9622981 A

Abstract (en)

[origin: WO9819679A1] The use of derivatives of theophylline for the preparation of medicaments suitable for the treatment of Cystic Fibrosis is described. In particular, the use of 8-cyclopentyl theophylline (CPT) is described for the preparation of medicaments for the treatment of cystic fibrosis. Such medicaments may be administered orally or directly to the lung, for example, in the form of an aerosol.

IPC 1-7 (main, further and additional classification)

A61K 31/52

IPC 8 full level (invention and additional information)

A61K 31/522 (2006.01); C07D 473/06 (2006.01)

CPC (invention and additional information)

C07D 473/06 (2013.01); A61K 31/522 (2013.01)

Citation (search report)

See references of WO 9819679A1

Designated contracting state (EPC)

AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

EPO simple patent family

WO 9819679 A1 19980514; AU 4875197 A 19980529; CA 2270355 A1 19980514; EP 0973521 A1 20000126; GB 9622981 D0 19970108

INPADOC legal status

2001-01-03 [18W] WITHDRAWN

- Date of withdrawal: 20001024

2000-01-26 [17P] REQUEST FOR EXAMINATION FILED

- Effective date: 19990429

2000-01-26 [AK] DESIGNATED CONTRACTING STATES:

- Kind Code of Ref Document: A1

- Designated State(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE